COMP <GO>
PBYI vs JNJ // PIOTROSKI F-SCORE QUALITY
Puma Biotechnology Inc (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: PBYI 5
— JNJ 6
■ METRIC PARITY
LAST: $10.44 (-0.95%) • MKT CAP: $544.1M
piotroski-score
8/9
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PBYI VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PBYI | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.50% | 67.90% | +6.60 | PBYI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 29.30% | 25.50% | +3.80 | PBYI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.8x | 18.5x | -4.70 | PBYI | /valuation <GO> |
| Free Cash Flow Yield | 7.67% | 2.97% | +4.70 | PBYI | /fcf-yield <GO> |
| Operating Margin | 16.30% | 34.70% | -18.40 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 13.60% | 28.50% | -14.90 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | -0.90% | 6.00% | -6.90 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.59 | -5.39 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.5 | 62.1 | -7.60 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.3x | 23.0x | -6.70 | PBYI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $544.1M | $662.49B | -$661.95B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PBYI REV | JNJ REV | PBYI GROSS % | JNJ GROSS % | PBYI FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $228.4M | $94.19B | 74.5% | 67.9% | $41.7M | $19.70B |
| FY 2024 | $230.5M | $88.82B | 72.1% | 69.1% | $38.9M | $19.84B |
| FY 2023 | $235.6M | $85.16B | — | — | $27.0M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PBYI // BETA —
JNJ // BETA 1.08